Related Experiment Video
Updated: Jul 12, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Optimizing in-kind drug donations for Tanzania-a case study.
Gaby Gehler Mariacher1, Deo Mtasiwa, Karin Wiedenmayer
1Swiss Tropical Institute, Basel, Switzerland. gema@bluewin.ch
The International Journal of Health Planning and Management
|September 7, 2007
Summary
In-kind drug donations (DDs) are vital for Tanzania
Area of Science:
- Health Systems Strengthening
- Pharmaceutical Management
- International Health
Background:
- In-kind drug donations (DDs) are crucial for addressing drug supply gaps in Tanzania.
- Previous studies highlighted issues of insufficient quantity and misalignment between donor supply and recipient needs.
Purpose of the Study:
- To discuss findings from a questionnaire survey on drug donations.
- To gather insights from key informants (KIs) on improving the drug donation process.
Main Methods:
- Qualitative data collection through key informant interviews.
- Conducted between 2001 and 2002 in Tanzania.
Main Results:
- Key informants confirmed the importance of drug donation guidelines and government implementation.
- Respondents stressed the need for donors to meet regulatory requirements and adapt donation quality to national standards.
- Identified improvements include guideline implementation, data availability, transparency, and accountability.
Conclusions:
- Effective implementation of drug donation guidelines is essential.
- Improved data sharing, transparency, and accountability can enhance the drug donation process.
- Aligning donations with national regulatory and quality assurance procedures is critical.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...